The world's #1 maker of dental handpieces under the NSK brand — a Japanese niche-top precision-instrument company with ~88% of sales earned across 140 countries.

Introducing a cleaning bottle for the PROFIX AIR-SYSTEM series airbrushes. [One Piece Cleaning] The body is clear glass, so you can see the condition of the paint collected within a glance. [2 Kinds of Hangers] An additional hanger is included to accommodate many handpieces (small) used in conjunction with various PROFIX handpieces. Ready to use. Japanese instruction manual included. Also comes with 10 extra filters so you can change it out when it gets dirty. (Safe 1 Year Manufacturer's Warranty) Not only does this product defects, but we also respond to any questions regarding how to use it in Japan.

The control of aspiration contamination of dental handpiece (DHP) is crucial for mitigating cross-infection risks associated with dental chair units (DCU) and DHP. However, the anti-aspiration capabil...

Direct Supplier of 808 nm Diode Stacks & Laser Repair Components Factory prices • No middlemen • Worldwide shipping from China

The world's #1 maker of dental handpieces under the NSK brand — a Japanese niche-top precision-instrument company with ~88% of sales earned across 140 countries.

PROCEPT BioRobotics (Nasdaq: PRCT) reported second quarter 2026 revenue of $94.5 million, up 19% year over year, driven by higher U.S. handpiece, system, and international revenue. U.S. revenue grew 20% to $83.4 million, including $48.4 million from handpieces and consumables and $29.1 million from systems.The Company delivered 65 U.S. HYDROS systems, including 14 replacements, with new system ASPs around $495,000. Second quarter U.S. procedures exceeded 13,100, up about 21%, with handpiece ASP rising 11% to $3,550. Gross margin improved to 66%, supported by pricing and a $2.9 million tariff refund, while operating expenses increased to $89.8 million. Net loss was $26.9 million (loss per share $0.47), and adjusted EBITDA loss was $11.3 million. Cash, cash equivalents and restricted cash totaled about $231 million at June 30, 2026.According to the company, full‑year 2026 revenue guidance of $390–$410 million, gross margin of about 65%, U.S. procedure volume of 54,000–56,000, and adjusted EBITDA loss of $35–$30 million is reiterated or updated.

Iridex (Nasdaq: IRIX) expanded its partnership with ophthalmology-focused group purchasing organization EyeProGPO by adding Iridex’s EndoProbe® Handpieces to the EyeProGPO product offering. More than 4,300 EyeProGPO members now gain access to preferred pricing on these single-use vitreoretinal laser delivery devices.The addition complements Iridex’s existing EyeProGPO portfolio, which already includes PASCAL®, IQ 532®, IQ 577®, OcuLight® TX, Cyclo G6® laser consoles and MicroPulse P3®, G-Probe®, and G-Probe Illuminate® devices. According to Iridex, the expanded agreement is intended to broaden member access to its retina laser systems and support ophthalmic providers with a wider range of EndoProbe models and gauges.

The Arduino kit that taught 2 million people to build hardware → Shop now on Amazon.